Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 10
Submit an article Journal homepage
145
Views
1
CrossRef citations to date
0
Altmetric
Letter

Leukemic transformation in patients with myelodysplastic syndromes after treatment with granulocyte colony-stimulating factor

Panagiotis T. DiamantopoulosHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, GreeceCorrespondence[email protected]
,
Titika ChatzileonidaHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Athanasios GalanopoulosDepartment of Clinical Hematology, “G. Gennimatas” District General Hospital, Athens, Greece
,
Xanthi YiakoumisHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Angeliki-Maria SaridakiHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Antonios AngelidisDepartment of Clinical Hematology, “G. Gennimatas” District General Hospital, Athens, Greece
,
Evangelos PapakostasHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Efthymia BazanisHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Sotirios SachanasHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Maria MichaelHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Gerassimos A. PangalisHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Nikolaos I. AnagnostopoulosDepartment of Clinical Hematology, “G. Gennimatas” District General Hospital, Athens, Greece
,
John MeletisHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
&
Nora-Athina ViniouHematology Unit, 1st Department of Internal Medicine, “Laikon” General Hospital, National and Kapodistrian University of Athens, Athens, Greece
 show all
Pages 2069-2072 | Received 25 Oct 2011, Accepted 16 Feb 2012, Published online: 09 Apr 2012

References

  • Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999; 340:1649–1660.
  • Swerdlow SH, Campo E, Harris NL, ., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.
  • Terpos E, Mougiou A, Kouraklis A, . Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients. Br J Haematol 2002;118: 174–180.
  • Golshayan AR, Jin T, Maciejewski J, . Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes. Br J Haematol 2007;137:125–132.
  • Park S, Grabar S, Kelaidi C, . Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Blood 2008;111:574–582.
  • Jädersten M, Montgomery SM, Dybedal I, . Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood 2005;106:803–811.
  • Hellström-Lindberg E, Gulbrandsen N, Lindberg G, . A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. Br J Haematol 2003;120: 1037–1046.
  • Jädersten M, Malcovati L, Dybedal I, . Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. J Clin Oncol 2008;26:3607–3613.
  • Socie G, Mary JY, Schrezenmeier H, . Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood 2007;109: 2794–2796.
  • Rosenberg PS, Zeidler C, Bolyard AA, . Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 2010;150:196–199.
  • Beekman R, Touw IP.G-CSF and its receptor in myeloid malignancy. Blood 2010;115:5131–5136.
  • Hellström-Lindberg E, Malcovati L. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes. Semin Hematol 2008;45:14–22.
  • Lindberg EH. Strategies for biology- and molecular-based treatment of myelodysplastic syndromes. Curr Drug Targets 2005;6: 713–725.
  • Greenberg P, Taylor K, Larson R, . Phase III randomized multicenter trial of G-CSF vs observation for myelodysplastic syndromes (MDS). Blood 1993;82(Suppl. 1): Abstract 196.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.